Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashFree Cash FlowNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adial Pharmaceuticals (ADIL) Cash from Discontinued Operations (2022 - 2023)

Adial Pharmaceuticals' Cash from Discontinued Operations history spans 2 years, with the latest figure at 17585.0 for Q4 2023.

  • For Q4 2023, Cash from Discontinued Operations rose 94.92% year-over-year to 17585.0; the TTM value through Dec 2023 reached 1003441.0, changed N/A, while the annual FY2023 figure was 1003441.0, 61.29% up from the prior year.
  • Cash from Discontinued Operations for Q4 2023 was 17585.0 at Adial Pharmaceuticals, up from 225015.0 in the prior quarter.
  • Across five years, Cash from Discontinued Operations topped out at 17585.0 in Q4 2023 and bottomed at 928092.0 in Q3 2022.